1-8 of 8
Zhongde Wang
Close
Sort by
Journal Articles

Endogenous oncogenic Nras mutation initiates hematopoietic malignancies in a dose- and cell type-dependent manner

Jinyong Wang, Yangang Liu, Zeyang Li, Zhongde Wang, Li Xuan Tan, Myung-Jeom Ryu, Benjamin Meline, Juan Du, Ken H. Young, Erik Ranheim, Qiang Chang, Jing Zhang
Journal: Blood
Blood (2011) 118 (2): 368–379.
https://doi.org/10.1182/blood-2010-12-326058
Published: 2011
Includes: Supplemental data
Journal Articles

Endogenous Oncogenic Nras Mutation Initiates T-Cell Leukemia/Lymphoma In a Dose-Dependent Manner

Jinyong Wang, PhD, Zeyang Li, PhD, Zhongde Wang, PhD, Yangang Liu, PhD, Myung-Jeom Ryu, PhD, Benjamin Meline, PhD, Juan Du, PhD, Ken H Young, PhD, Qiang Chang, Jing Zhang, PhD
Journal: Blood
Blood (2010) 116 (21): 4183.
https://doi.org/10.1182/blood.V116.21.4183.4183
Published: 2010
Journal Articles

Pre-Clinical Development of a Subunit Vaccine Expressing an IE1-IE2 Fusion Protein of HCMV.

Zhongde Wang, PHD, Wendy Zhou, PHD, MD, Tumul Srivastava, PHD, Corinna La Rosa, PHD, Stephen J. Forman, MD, John A. Zaia, MD, Don J. Diamond, PhD
Journal: Blood
Blood (2007) 110 (11): 165.
https://doi.org/10.1182/blood.V110.11.165.165
Published: 2007
Journal Articles

Vaccine Properties of a Novel Marker Gene-Free Recombinant Modified Vaccinia Ankara (MVA) Expressing Immunodominant CMV Antigens.

Don J. Diamond, PhD, Zhongde Wang, PhD, Corinna La Rosa, PhD, Tumul Srivastava, PHD, Wendy Zhou, MD, PHD, Zhongqi Li, PhD, Heang Ly, Tamineh Akbarnejad, MS, Aparna Krishnan, MS, William J. Britt, MD
Journal: Blood
Blood (2006) 108 (11): 2858.
https://doi.org/10.1182/blood.V108.11.2858.2858
Published: 2006
Journal Articles

Development and Immunologic Characterization of Multi-Antigen Expressing Attenuated Poxviruses for Immunotherapy of CMV Infection in HSCT Recipients.

Don J. Diamond, PhD, Zhongde Wang, PhD, Corinna La Rosa, PhD, Goetz U. Grigoleit, MD, Angelo Mandarino, PhD, Simon F. Lacey, PhD, Holger Ludwig, PhD, William J. Britt, MD, Gerd Sutter, PhD, Hermann Einsele, MD
Journal: Blood
Blood (2005) 106 (11): 480.
https://doi.org/10.1182/blood.V106.11.480.480
Published: 2005
Journal Articles

Rapid Ex Vivo Expansion of CMV Specific CTL Suitable for Clinical Immunotherapy Using CpG-DNA Matured PBMC Infected with Recombinant MVA.

Don J. Diamond, PhD, Zhongde Wang, PhD, Simon F. Lacey, PhD, Corinna La Rosa, PhD
Journal: Blood
Blood (2004) 104 (11): 5102.
https://doi.org/10.1182/blood.V104.11.5102.5102
Published: 2004
Journal Articles

Attenuated poxviruses generate clinically relevant frequencies of CMV-specific T cells

Zhongde Wang, Corinna La Rosa, Shahram Mekhoubad, Simon F. Lacey, Maria C. Villacres, Susan Markel, Jeff Longmate, Joshua D. I. Ellenhorn, Robert F. Siliciano, Christopher Buck, William J. Britt, Don J. Diamond
Journal: Blood
Blood (2004) 104 (3): 847–856.
https://doi.org/10.1182/blood-2003-10-3469
Published: 2004
Journal Articles

Preclinical development of an adjuvant-free peptide vaccine with activity against CMV pp65 in HLA transgenic mice

Corinna La Rosa, Zhongde Wang, John C. Brewer, Simon F. Lacey, Maria C. Villacres, Rahul Sharan, Radhika Krishnan, Matthew Crooks, Susan Markel, Rebecca Maas, Don J. Diamond
Journal: Blood
Blood (2002) 100 (10): 3681–3689.
https://doi.org/10.1182/blood-2002-03-0926
Published: 2002